The survival rate for children with congenital heart disease (CHD) has increased significantly coincident with improved techniques in cardiothoracic surgery, cardiopulmonary bypass and myocardial protection, and perioperative care. Cardiopulmonary bypass, likely in combination with ischemia-reperfusion injury, hypothermia, and surgical trauma, elicits a complex, systemic inflammatory response that is characterized by activation of the complement cascade, release of endotoxin, activation of leukocytes and the vascular endothelium, and release of proinflammatory cytokines. This complex inflammatory state causes a transient immunosuppressed state, which may increase the risk of hospital-acquired infection in these children. Postoperative sepsis occurs in nearly 3% of children undergoing cardiac surgery and has been associated with longer length of stay and mortality risks in the pediatric cardiac intensive care unit. Herein, we review the epidemiology, pathobiology, and management of sepsis in the pediatric cardiac intensive care unit.
The Scope of the Problem
The diagnosis of sepsis is based upon the clinical recognition of a constellation of several, fairly consistent clinical signs and symptoms that occur in association with an infection or other inciting event, for example, trauma, pancreatitis, cardiopulmonary bypass, or burns. Roger Bone first coined the term sepsis syndrome in 1989, 1 and shortly thereafter, an international panel of experts from the Society of Critical Care Medicine (SCCM) and the American College of Chest Physicians (ACCP) proposed the now familiar consensus definitions for the systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic shock ( Table 1) . 2 These definitions have been subsequently modified for use in critically ill children ( Table 2) 3 and are difficult to apply in children with congenital heart disease (CHD). For example, the vast majority of children with CHD following cardiopulmonary bypass probably satisfy the criteria for SIRS, especially within the first 24 hours after surgery. The sensitivity and specificity of these consensus criteria for the diagnosis of sepsis in children with CHD are therefore far from perfect.
Unfortunately, there are relatively few studies that have described either the epidemiology or impact of sepsis on critically ill children with CHD. [4] [5] [6] Most of these studies are limited to critically ill children who develop sepsis secondary to hospital-acquired infections (HAIs), including (in decreasing order of frequency and importance in the cardiac intensive care unit [CICU]) catheter-associated bloodstream infections (CA-BSIs), ventilator-associated respiratory infections (VARIs), surgical site infections (SSIs), and catheter-associated urinary tract infections (CA-UTIs). [7] [8] [9] [10] [11] [12] [13] [14] Barker 
The PIRO Concept
The consensus definitions for sepsis provide a general framework for epidemiologic investigation, as well as provide consistent and relatively straightforward inclusion criteria for clinical trials. However, most experts recognize that these definitions are far from perfect, [15] [16] [17] especially in children with CHD. As a result, several experts from SCCM and ACCP reconvened in December 2001 and proposed a new staging system for sepsis. 18 The ''PIRO'' staging system for sepsis is modeled after the TNM (Tumor, Nodes, Metastasis) system 19 for staging cancer and stratifies patients on the basis of their Predisposing conditions, the nature and extent of the insult (Infection), the nature and magnitude of the host Response, and the degree of concomitant Organ dysfunction. The PIRO staging system has many favorable attributes but will require thorough validation and testing before it is widely adopted and applied in clinical practice. [20] [21] [22] [23] [24] Given the lack of sensitivity and specificity of the current consensus definitions for pediatric Sepsis plus either cardiovascular dysfunction or acute respiratory distress syndrome (ARDS) or 2 or more other organ dysfunctions (see Table 4 ) Septic shock Sepsis and cardiovascular organ dysfunction, as described in Table 4 .
Adapted from Goldstein et al. 3 sepsis in children with CHD, the PIRO staging system may have more relevance in the CICU. Again however, there are no studies that have assessed the PIRO staging system in critically ill children with CHD ( Table 3 ).
Predisposition
There are numerous factors that may increase the risk and severity of sepsis. Certainly, age (increased mortality at the extremes of age-both young and old), [25] [26] [27] gender (increased severity of illness and mortality in males compared to females), 28, 29 nutritional status (increased morbidity and mortality with malnutrition or obesity), [30] [31] [32] and chronic diseases 25, 26, 33 are important. Genetic factors (see also below) likely play an important role as well, and there are several gene polymorphisms that have been linked with an increased susceptibility to sepsis. 34 Aside from these factors, there are likely several reasons that children with CHD are at a particularly increased risk. First, there are several well-described malformation syndromes (eg, 22q11 deletion or DiGeorge sequence) and chromosomal syndromes (trisomy 21) that are associated with congenital heart malformations and defects in immunity or an increased risk of infection. For example, several immunologic defects have been described in children with trisomy 21, 35, 36 which in combination with CHD may confer an increased risk of infection. 37 In addition, children with trisomy 21 have a higher risk of mortality from sepsis. 38 Second, the chronic hypoxia associated with cyanotic CHD likely affects the host immune response. 39 Third, children with CHD are exposed to invasive devices and technology, which carry an increased risk of HAI. [40] [41] [42] [43] Fourth, children who undergo heart or heart/lung transplantation require life-long immunosuppression to prevent graft rejection, which increases the risk of infection. Finally, CPB, likely in combination with ischemia-reperfusion injury, hypothermia, and surgical trauma, elicits a complex, systemic inflammatory response that is characterized by activation of the complement cascade, release of endotoxin, activation of leukocytes and the vascular endothelium, and release of proinflammatory cytokines. 44 The complex humoral and cellular-mediated immune response to CPB and surgical stress results in a transient and relative state of immune suppression, often referred to as immune paralysis (immunoparalysis). [44] [45] [46] For example, whole blood obtained from children following CPB stimulated ex vivo with lipopolysaccharide (LPS) results in markedly diminished proinflammatory cytokine production, 45 consistent with the phenomenon known as ''endotoxin tolerance.'' 47 This state of immunoparalysis may result in an increased risk of sepsis in children undergoing cardiac surgery. 7, 9, 40, 42, 43, 48 Infection/Insult
There are likely important host-pathogen interactions that affect the response to therapy and outcome, which have been reviewed elsewhere. [49] [50] [51] In the interests of space limitation, these will not be reviewed again here.
Response
Individual differences in the host response to sepsis may also depend to a significant extent upon an individual's particular genetic makeup. While no clear ''sepsis gene'' has been identified, genetic factors undoubtedly play an important role in the pathophysiology of sepsis. 34, [52] [53] [54] Sorensen and colleagues 55 conducted a longitudinal cohort study involving over 900 adopted children born between 1924 and 1926. The adopted children and both their biologic and adoptive parents were followed until 1982. The death of a biologic parent before age 50 years resulted in a significantly increased risk of death in the adopted children (relative risk [RR] 1.71, 95% confidence interval [CI] 1.14-2.57) for all causes. Of greater interest, if a biologic parent died of infection before the age of 50 years, the RR of death from infectious causes in the child was highly significant, with an RR of 5.81 (95% CI 2.47-13.7), which was higher than the increased risk of dying from cardiovascular disease or cancer, 2 conditions with well-accepted genetic components. In contrast, the death of an adoptive parent from infectious causes did not confer a greater risk of death in the adopted child. The prevailing evidence suggests that the individual response to sepsis is quite heterogeneous and that a ''one-size fits all'' approach to treatment is not likely to be successful. Sepsis results from a dysregulated host response, such that the balance between the proinflammatory mechanisms that are largely responsible for combating infection and the compensatory, anti-inflammatory mechanisms that counteract, ''fine-tune,'' and regulate these mechanisms largely determines the nature of the host response. For example, a shift in the homeostatic balance to a predominantly anti-inflammatory phenotype leads to a state of relative immune suppression or immunoparalysis, resulting in an inability to clear the pathogen and hence an increased risk of HAI. 56, 57 These patients would benefit from therapies that are designed to augment or stimulate the host immune response, for example interferon-g [58] [59] [60] and/or granulocyte-macrophage colonystimulating factor (GM-CSF). [61] [62] [63] [64] [65] Conversely, a shift in balance toward a predominantly proinflammatory phenotype results in further cellular injury, multiple organ failure, and death. These patients, on the other hand, would benefit from therapies that are designed to suppress or attenuate the host immune response. It is the nature of the host response, then, that largely determines the type of therapy required-either stimulation or attenuation of the host response to infection. 54, 66 We believe that a strategy based upon ''the right therapy, at the right time, in the right patient'' will achieve the best possible outcome. The use of biomarkers 67 or gene expression profiling 68 will hopefully facilitate proper selection of the best therapy for critically ill children with sepsis.
Organ Dysfunction/Failure
Sepsis is characterized by a triad of inflammation, endothelial dysfunction, and alterations in the coagulation systems, which lead to perturbations in the delivery of oxygen and metabolic substrates to the tissues. These perturbations, in turn, lead to multiple organ dysfunction syndrome ([MODS] Table 4 ) and ultimately death. While relatively uncommon, MODS is associated with significant morbidity and mortality in critically ill children with CHD following cardiac surgery. [69] [70] [71] For example, Ben-Abraham and colleagues 71 showed that 80% all deaths occurring during the first postoperative week in their series were caused by MODS. Mortality is higher with increased numbers of organ systems failures. Acute kidney injury (AKI), in particular, appears to be an independent risk factor for mortality in this population. [72] [73] [74] [75] Therefore, both the number and type of organ failures likely affect the outcomes in critically ill children with sepsis and CHD.
Management of Sepsis in the Pediatric CICU
The American College of Critical Care Medicine (ACCM) Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock were published in 2002 as a set of ''best clinical practices'' for the management of critically ill neonates and children with septic shock. 76 While these guidelines have not been rigorously tested in a randomized, controlled clinical trial, early resuscitation and reversal of shock has improved outcome in critically ill children with septic shock. 77, 78 In addition, a randomized open-label clinical trial in Brazil showed that management targeted to superior vena cava oxygen saturation (ScvO 2 ) using these guidelines resulted in a significant reduction in 28-day mortality (39.2% vs 11.8%, P ¼ .002). 79 These guidelines were updated and revised in 2007. 80 Unfortunately, there are few studies which have described the management of critically ill children with either unrepaired or palliated CHD and sepsis. Given the underlying differences in cardiac function, the presence of left-sided or right-sided obstructive lesions, or relative balance between the systemic and pulmonary circulations in these children, the strategies addressed in the ACCM Clinical Practice Parameters may adversely impact the care of these fragile patients. Future studies are clearly necessary and warranted.
Unanswered Questions
Several unanswered questions for the management of critically ill neonates and children with sepsis and underlying CHD remain. First, as discussed above, there are few epidemiologic studies available to assess the impact of the presence of underlying heart disease and/or chronic hypoxemia on the outcome from sepsis. Second, there is an urgent need for better biomarkers for risk stratification and therapeutic monitoring in this population. Third, we need to understand the impact of CHD, and in particular, the effects of cardiopulmonary bypass, on the subsequent risk of HAIs, such as VARI, CA-BSI, and CA-UTI. Proven need or >50% FIO 2 to maintain saturation 92% Need for nonelective invasive or noninvasive mechanical ventilation Neurologic dysfunction One of the following criteria:
Glasgow Coma score 11 Acute change in mental status with a decrease in Glasgow Coma Score 3 points from abnormal baseline Hematologic dysfunction:
One of the following criteria: Platelet count < 80 000/mm 3 or a decline of 50% in platelet count from highest value recorded over the past 3 days (for chronic hematology/oncology patients) International normalized ratio 2 Renal dysfunction: Serum creatinine 2 times upper limit of normal for age or 2-fold increase in baseline Hepatic dysfunction:
One of the following criteria: Total bilirubin 4 mg/dL (not applicable for newborn) ALT 2 times upper limit of normal for age Abbreviation: FIO 2, fraction of inspired oxygen. Adapted from Goldstein et al. 3 In addition, more studies regarding prevention and compliance with infection control/prevention are needed in this population. Finally, we need to better understand the nuances of managing critically ill children with cyanotic CHD and sepsis.
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